BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38790996)

  • 1. Are Young People with Turner Syndrome Who Have Undergone Treatment with Growth and Sex Hormones at Higher Risk of Metabolic Syndrome and Its Complications?
    Krzyścin M; Sowińska-Przepiera E; Gruca-Stryjak K; Soszka-Przepiera E; Syrenicz I; Przepiera A; Bumbulienė Ž; Syrenicz A
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38790996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Body Composition Increases the Cardiometabolic Risk in Adolescents and Young Adults With Turner Syndrome.
    Mondal S; Gargari P; Bose C; Garg MK; Chowdhury S; Mukhopadhyay S
    Endocr Pract; 2024 Mar; 30(3):259-269. PubMed ID: 38042448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epicardial and Perihepatic Fat as Cardiometabolic Risk Predictors in Girls with Turner Syndrome: A Cardiac Magnetic Resonance Study.
    Salem NA; Batouty NM; Tawfik AM; Sobh DM; Gadelhak B; Hendawy SR; Laimon W
    J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):408-417. PubMed ID: 34013713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome.
    O'Gorman CS; Syme C; Lang J; Bradley TJ; Wells GD; Hamilton JK
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):907-13. PubMed ID: 23106295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into clinical features, karyotypes, and age at diagnosis in women with Turner syndrome.
    Frelich J; Irzyniec T; Lepska K; Jeż W
    Endokrynol Pol; 2019; 70(4):342-349. PubMed ID: 31073987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isochromosome Xq and the risk of metabolic comorbidities in Turner syndrome.
    Malhotra R; Shukla R; Rastogi V; Khadgawat R
    Diabetes Metab Syndr; 2023 Feb; 17(2):102708. PubMed ID: 36696722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Natural History of Metabolic Comorbidities in Turner Syndrome from Childhood to Early Adulthood: Comparison between 45,X Monosomy and Other Karyotypes.
    Lebenthal Y; Levy S; Sofrin-Drucker E; Nagelberg N; Weintrob N; Shalitin S; de Vries L; Tenenbaum A; Phillip M; Lazar L
    Front Endocrinol (Lausanne); 2018; 9():27. PubMed ID: 29479339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthropometric variables as cardiovascular risk predictors in a cohort of adult subjects with Turner syndrome.
    Álvarez-Nava F; Racines M; Witt J; Guarderas J; Estévez M; Lanes R
    Diabetes Metab Syndr Obes; 2019; 12():1795-1809. PubMed ID: 31571955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in Turner syndrome and relation between body composition and clinical, genetic, and ultrasonographic characteristics.
    Calcaterra V; Brambilla P; Maffè GC; Klersy C; Albertini R; Introzzi F; Bozzola E; Bozzola M; Larizza D
    Metab Syndr Relat Disord; 2014 Apr; 12(3):159-64. PubMed ID: 24447068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiometabolic and vascular risks in young and adolescent girls with Turner syndrome.
    Mavinkurve M; O'Gorman CS
    BBA Clin; 2015 Jun; 3():304-9. PubMed ID: 26673162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.
    Qing L; Wei R; Chan L; Xiaoya Z; Xin X
    J Endocrinol Invest; 2017 Jun; 40(6):653-661. PubMed ID: 28233232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interplay between Muscular Grip Strength and Bone Mineral Density with Consideration of Metabolic and Endocrine Parameters in Individuals with Turner Syndrome.
    Krzyścin M; Gruca-Stryjak K; Soszka-Przepiera E; Syrenicz I; Przepiera A; Cymbaluk-Płoska A; Bumbulienė Ž; Sowińska-Przepiera E
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules.
    Gravholt CH; Hjerrild BE; Mosekilde L; Hansen TK; Rasmussen LM; Frystyk J; Flyvbjerg A; Christiansen JS
    Eur J Endocrinol; 2006 Oct; 155(4):583-92. PubMed ID: 16990658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Syndrome as a Risk Factor for Sensorineural Hearing Loss in Adult Patients with Turner Syndrome.
    Álvarez-Nava F; Racines-Orbe M; Witt J; Guarderas J; Vicuña Y; Estévez M; Lanes R
    Appl Clin Genet; 2020; 13():25-35. PubMed ID: 32021381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment.
    Visser JA; Hokken-Koelega AC; Zandwijken GR; Limacher A; Ranke MB; Flück CE
    Hum Reprod; 2013 Jul; 28(7):1899-907. PubMed ID: 23539612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequencies and distributions of sex chromosome abnormalities in females with the Turner phenotype: a long-term retrospective study in the southern region of Turkey.
    Tanrıverdi N; Demirhan O; Süleymanova D; Pazarbaşı A
    Turk J Med Sci; 2017 Nov; 47(5):1447-1455. PubMed ID: 29151316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome.
    El-Mansoury M; Barrenäs ML; Bryman I; Hanson C; Larsson C; Wilhelmsen L; Landin-Wilhelmsen K
    Clin Endocrinol (Oxf); 2007 May; 66(5):744-51. PubMed ID: 17381484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyotype classification, clinical manifestations and outcome in 124 Turner syndrome patients in China.
    Wu HH; Li H
    Ann Endocrinol (Paris); 2019 Feb; 80(1):10-15. PubMed ID: 29580553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age.
    Fechner PY; Davenport ML; Qualy RL; Ross JL; Gunther DF; Eugster EA; Huseman C; Zagar AJ; Quigley CA;
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4896-902. PubMed ID: 16968797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.